Byotrol stock opened at GBX 2.90 ($0.04) on Wednesday. Byotrol has a 12 month low of GBX 3 ($0.04) and a 12 month high of GBX 6 ($0.08).
In other news, insider David Traynor bought 4,840,628 shares of the company’s stock in a transaction on Wednesday, January 17th. The stock was purchased at an average cost of GBX 3 ($0.04) per share, for a total transaction of £145,218.84 ($205,256.31).
Byotrol plc develops, patents, and sells products based on anti-microbial technology in the United Kingdom, North America, and internationally. The company operates through three segments: Professional, Consumer, and Pet. It offers Actizone products, anti-viral hand foams, bathroom cleaners, antimicrobial surface and hand sanitizers, antimicrobial sanitizing wipes, grooming products, multi-purpose cleaners, and multi-surface cleaners.
Receive News & Ratings for Byotrol Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Byotrol and related companies with MarketBeat.com's FREE daily email newsletter.